Our drugs engage the immune system to fight tumors
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
No comments yet. Be the first!
Real conversations about Eris Biotech on X
Post on X
